Anti-asparaginyl tRNA synthetase (Anti-KS) antibody-positive pneumonitis in a patient with immune checkpoint inhibitor treatment: A case report and literature review.

Immune checkpoint inhibitors anti-tRNA synthetase (anti-ARS) antibody syndrome immune-related adverse events (irAEs)

Journal

Modern rheumatology case reports
ISSN: 2472-5625
Titre abrégé: Mod Rheumatol Case Rep
Pays: England
ID NLM: 101761026

Informations de publication

Date de publication:
05 Aug 2024
Historique:
received: 21 03 2024
accepted: 05 08 2024
medline: 5 8 2024
pubmed: 5 8 2024
entrez: 5 8 2024
Statut: aheadofprint

Résumé

In recent years, the use of immune checkpoint inhibitors (ICI) has increased and there have been case reports of anti- aminoacyl tRNA synthetase (ARS) antibody syndrome during ICI treatment. However, these cases are limited, and their clinical characteristics are not fully understood. We report the first case of anti ARS antibody syndrome with KS antibody during ICI therapy. This report presents our case, along with a literature review of other anti ARS antibody syndrome cases that developed after ICI use, discussing their clinical characteristics and possible mechanisms of onset. Considering the widespread use of ICI in cancer therapy, we should aware of anti ARS antibody syndrome that develops during use of ICI .

Identifiants

pubmed: 39101392
pii: 7727371
doi: 10.1093/mrcr/rxae043
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Japan College of Rheumatology 2024. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.

Auteurs

Nobuhiro Oda (N)

Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Okuto Koguchi (O)

Department of Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Hiroki Kontani (H)

Department of Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Jun Hayashi (J)

Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Ryo Hazue (R)

Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Yu Oyama (Y)

Department of Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Ryo Rokutanda (R)

Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Classifications MeSH